With medical device companies seizing the opportunity to move into robotic surgery, market leader Intuitive Surgical is facing intense competition. The California-based company has dominated the field for over 20 years but with the opening of a new UK and Ireland HQ, (Also see "Intuitive Surgical Opens New UK/Ireland HQ In Oxfordshire" - Medtech Insight, 4 September, 2019.) it has no plans to surrender to competition. Medtech Insight chats with CEO Gary Guthart, a California native who has been with the company since its inception in 1996 and served as CEO since 2010.
Exec Chat: Intuitive Surgical CEO Gary Guthart On Expansion, Innovation And Competition
Listen to this article
With the opening of a new UK & Ireland headquarters last month, Intuitive Surgical is aiming to strengthen its grip on the the market as it faces increasing competition in the robotic surgery space. CEO Gary Guthart sat down with Medtech Insight at its new Oxfordshire, UK HQ to discuss expansion and innovation plans.
Keep up with the top medtech business and regulatory news.
More from Strategy
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
- • By
Spain has one of the highest incarceration rates in Europe, with 160 individuals imprisoned per 100,000 residents. In 2020, 43,494 people were incarcerated in facilities not managed by regional health authorities — essentially all regions except Catalonia, the Basque Country, and Navarra.
- • By
This week, Neuralink announced it received US FDA breakthrough device designation for a device to restore sight; medtechs Discure and DeepLook secured new funding; FDA pump recalls from B. Braun Medical and Fresenius Kabi; Axonics prevails in patent infringement lawsuit with Medtronic; Merit Medical buys Cook Medical for $210m.
- • By
The US FDA released six more device classifications in early September, including products from Edwards, Interscope, and Baxter Healthcare.
More from Business
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
